Comparing the current results to its competitors, Outset Medical Inc reported Revenue decrease in the 1 quarter 2026 year on year by -6.78 %, despite the revenue increase by the most of its competitors of 2.99 %, recorded in the same quarter.
Outset Medical Inc , slower than the average decrease reported by the company's competitors of -14.49 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -14.49 %
September 9, 2024
Shareholder Class Action Lawsuit Filed Against Outset Medical, Inc. (NASDAQ: OM): Investors Advised to Seek Legal Counsel Investors holding shares in Outset Medical, Inc. (NASDAQ: OM) have recently been alerted to a class action lawsuit filed against the company. The lawsuit encompasses allegations that could have significant repercussions for the stakeholders involved. In light of these developments, investors who have incurred losses are being encouraged to consult with legal professionals to better understand their rights and options moving forward.Outset Medical, known for its innovative technology in the area of dialysis treatment, now finds itself embroiled in a legal battle that could impact its finan...
Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.
Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.
DaVita Inc. operates a network of dialysis centers, focusing on kidney care and related services for patients with chronic kidney disease. It generates revenue primarily through reimbursements from healthcare payors and government programs for dialysis treatments.
Fresenius Medical Care AG & Co. KGaA is a global healthcare company that specializes in providing services and products for patients with chronic kidney failure. Their business model focuses on offering a comprehensive range of innovative dialysis products, services, and patient care for individuals suffering from kidney-related issues. Through their network of clinics, dialysis centers, and manufacturing sites, they aim to provide high-quality renal care and improve the lives of patients worldwide.
ICU Medical Inc's business model focuses on the development, manufacture, and sale of innovative medical devices and solutions for critical care settings.
Sources:
Outset Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Outset Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
